Scopolamine effects on functional brain connectivity: A pharmacological model of Alzheimer's disease

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Bajo, R ^a   Pusil, S ^a   Lopez M E ^a   Canuet, L ^a   Pereda, E ^b   Osipova, D ^c   Maestu F ^a   Pekkonen, E ^c,d  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPYRRONIUM; SCOPOLAMINE BROMIDE;

AGED; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; FEMALE; HUMAN; MAGNETOENCEPHALOGRAPHY; MALE; MIDDLE AGED; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACEBO EFFECT; REST; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN MAPPING; FEMALE; GLYCOPYRROLATE; HUMANS; MAGNETOENCEPHALOGRAPHY; MALE; MIDDLE AGED; NEURAL PATHWAYS; PLACEBO EFFECT; REST; SCOPOLAMINE HYDROBROMIDE;

EID: 84934762257     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09748     Document Type: Article

References (39)

1. Friston, K. J. Functional and effective connectivity in neuroimaging: a synthesis. Hum. Brain Mapp. 2, 56-78 (1994).
2. Friston, K. J. Brain function, nonlinear coupling, and neuronal transients. Neuroscientist 7, 406-418 (2001).
3. Sporns, O., Chialvo, D. R., Kaiser, M. & Hilgetag, C. C. Organization, development and function of complex brain networks. Trends Cogn. Sci. 8, 418-25 (2004).
4. Pereda, E., Quiroga, R. Q. & Bhattacharya, J. Nonlinear multivariate analysis of neurophysiological signals. Prog. Neurobiol. 77, 1-37 (2005).
5. Stam, C. J. et al. Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain 132, 213-224 (2009).
6. Buldú, J. M. et al. Reorganization of functional networks in mild cognitive impairment. PLoS One 6, e19584 DOI: 10.1371/ journal.pone.0019584 (2011).
7. Achard, S. & Bullmore, E. Efficiency and cost of economical brain functional networks. PLoS Comput. Biol. 3, 0174-0183 (2007).
8. Spinks, A. & Wasiak, J. Scopolamine (hyoscine) for preventing and treating motion sickness. Cochrane database Syst. Rev. DOI:10.1002/14651858 (2011).
9. Reis, P. M. R., Eckhardt, H., Denise, P., Bodem, F. & Lochmann, M. Localization of scopolamine induced electrocortical brain activity changes, in healthy humans at rest. J. Clin. Pharmacol. 53, 619-625 (2013).
10. Jeong, J. EEG dynamics in patients with Alzheimer's disease. Clin. Neurophysiol. 115, 1490-1505 (2004).
11. Sannita, W. G., Maggi, L. & Rosadini, G. Effects of scopolamine (0.25-0.75 mg i.m.) on the quantitative EEG and the Neuropsychological status of healthy volunteers. Pharmacoelectroencephalography. 17, 199-205 DOI:10.1159/000118365 (1987).
12. Osipova, D. et al. Effects of scopolamine on MEG spectral power and coherence in elderly subjects. Clin. Neurophysiol. 114, 1902-1907 (2003).
13. Ebert, U. & Kirch, W. Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur. J. Clin. Invest. 28, 944-949 (1998).
14. Ebert, U., Grossmann, M., Oertel, R., Gramatté, T. & Kirch, W. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J. Clin. Pharmacol. 41, 51-60 (2001).
15. Sloan, E. P., Fenton, G. W. & Standage, K. P. Anticholinergic drug effects on quantitative electroencephalogram, visual evoked potential, and verbal memory. Biol. Psychiatry 31, 600-606 (1992).
16. Locatelli, T., Cursi, M., Liberati, D., Franceschi, M. & Comi, G. EEG coherence in Alzheimer's disease. Electroencephalogr. Clin. Neurophysiol. 106, 229-237 (1998).
17. Pijnenburg, Y. A. L. et al. EEG synchronization likelihood in mild cognitive impairment and Alzheimer's disease during a working memory task. Clin. Neurophysiol. 115, 1332-1339 (2004).
18. Stam, C. J. et al. Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage 32, 1335-1344 (2006).
19. Tzourio-Mazoyer, N. et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15, 273-89 (2002).
20. Tadel, F., Baillet, S., Mosher, J. C., Pantazis, D. & Leahy, R. M. Brainstorm: a user-friendly application for MEG/EEG analysis. Comput. Intell. Neurosci. DOI:10.1155/2011/879716 (2011).
21. Holmes, C. J. et al. Enhancement of MR images using registration for signal averaging. J. Comput. Assist. Tomogr. 22, 324-33 (1998).
22. Henson, R. N., Mattout, J., Phillips, C. & Friston, K. J. Selecting forward models for MEG source-reconstruction using modelevidence. Neuroimage 46, 168-176 (2009).
23. Mosher, J. C., Baillet, S. & Leahy, R. M. Equivalence of linear approaches in bioelectromagnetic inverse solutions. in IEEE Work. Stat. Signal Process. 2003 294-297 (IEEE, , 2003). DOI:10.1109/SSP.2003.1289402 (2003).
24. Mormann, F., Lehnertz, K., David, P. & E. Elger, C. Mean phase coherence as a measure for phase synchronization and its application to the EEG of epilepsy patients. Phys. D Nonlinear Phenom. 144, 358-369 (2000).
25. Rubinov, M. & Sporns, O. Complex network measures of brain connectivity: uses and interpretations. Neuroimage 52, 1059-1069 (2010).
26. Sporns, O. Network attributes for segregation and integration in the human brain. Curr. Opin. Neurobiol. 23, 162-171 (2013).
27. Sporns, O. Contributions and challenges for network models in cognitive neuroscience. Nat. Neurosci. 17, 652-60 (2014).
28. Bajo, R. et al. Functional connectivity in mild cognitive impairment during a memory task: implications for the disconnection hypothesis. J. Alzheimers. Dis. 22, 183-193 (2010).
29. Stam, C. J., Y, V. D. M., Yal, P. & Eeg, S. P. EEG synchronization in mild cognitive impairment and Alzheimer's disease. Acta Neurol. Scand. 108, 90-96 (2003).
30. Babiloni, C. et al. Mapping distributed sources of cortical rhythms in mild Alzheimer's disease. A multicentric EEG study. Neuroimage 22, 57-67 (2004).
31. Koenig, T. et al. Decreased EEG synchronization in Alzheimer's disease and mild cognitive impairment. Neurobiol. Aging 26, 165-171 (2005).
32. Sperling, R. A. et al. Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med. 12, 27-43 (2010).
33. Iturria-Medina, Y. et al. Characterizing brain anatomical connections using diffusion weighted MRI and graph theory. Neuroimage 36, 645-660 (2007).
34. Iturria-Medina, Y., Sotero, R. C., Canales-Rodríguez, E. J., Alemán-Gómez, Y. & Melie-García, L. Studying the human brain anatomical network via diffusion-weighted MRI and Graph Theory. Neuroimage 40, 1064-1076 (2008).
35. Wink, A. M., Bernard, F., Salvador, R., Bullmore, E. & Suckling, J. Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus. Neurobiol. Aging 27, 1395-1404 (2006).
36. Brier, M. R. et al. Loss of intranetwork and internetwork resting state functional connections with Alzheimer's disease progression. J. Neurosci. 32, 8890-8899 (2012).
37. Watts, D. & Strogatz, S. Collective dynamics of "small-world" networks. Nature 393, 440-442 (1998).
38. Zaidel, L. et al. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report. J. Alzheimers. Dis. 31 (Suppl 3), , S221-6 (2012).
39. Berendse, H. W., Verbunt, J. P., Scheltens, P., van Dijk, B. W. & Jonkman, E. J. Magnetoencephalographic analysis of cortical activity in Alzheimer's disease: a pilot study. Clin. Neurophysiol. 111, 604-612 (2000).